Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program

Linda M Delahanty, Qing Pan, Kathleen A Jablonski, Karol E Watson, Jeanne M McCaffery, Alan Shuldiner, Steven E Kahn, William C Knowler, Jose C Florez, Paul W Franks, Diabetes Prevention Program Research Group

Abstract

Objective: We tested genetic associations with weight loss and weight regain in the Diabetes Prevention Program, a randomized controlled trial of weight loss-inducing interventions (lifestyle and metformin) versus placebo.

Research design and methods: Sixteen obesity-predisposing single nucleotide polymorphisms (SNPs) were tested for association with short-term (baseline to 6 months) and long-term (baseline to 2 years) weight loss and weight regain (6 months to study end).

Results: Irrespective of treatment, the Ala12 allele at PPARG associated with short- and long-term weight loss (-0.63 and -0.93 kg/allele, P ≤ 0.005, respectively). Gene-treatment interactions were observed for short-term (LYPLAL1 rs2605100, P(lifestyle*SNP) = 0.032; GNPDA2 rs10938397, P(lifestyle*SNP) = 0.016; MTCH2 rs10838738, P(lifestyle*SNP) = 0.022) and long-term (NEGR1 rs2815752, P(metformin*SNP) = 0.028; FTO rs9939609, P(lifestyle*SNP) = 0.044) weight loss. Three of 16 SNPs were associated with weight regain (NEGR1 rs2815752, BDNF rs6265, PPARG rs1801282), irrespective of treatment. TMEM18 rs6548238 and KTCD15 rs29941 showed treatment-specific effects (P(lifestyle*SNP) < 0.05).

Conclusions: Genetic information may help identify people who require additional support to maintain reduced weight after clinical intervention.

Trial registration: ClinicalTrials.gov NCT00004992.

References

    1. Lindgren CM, Heid IM, Randall JC, et al. ; Wellcome Trust Case Control Consortium; Procardis Consortia; Giant Consortium Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet 2009;5:e1000508.
    1. Willer CJ, Speliotes EK, Loos RJ, et al. ; Wellcome Trust Case Control Consortium; Genetic Investigation of ANthropometric Traits Consortium Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009;41:25–34
    1. Li S, Zhao JH, Luan J, et al. Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study. PLoS Med 2010;7:e1000332.
    1. Knowler WC, Barrett-Connor E, Fowler SE, et al. ; Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403
    1. Rubin RR, Fujimoto WY, Marrero DG, et al. ; DPP Research Group The Diabetes Prevention Program: recruitment methods and results. Control Clin Trials 2002;23:157–171
    1. Franks PW, Jablonski KA, Delahanty L, et al. ; Diabetes Prevention Program Research Group The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 2007;50:2451–2460
    1. Hivert MF, Jablonski KA, Perreault L, et al. ; DIAGRAM Consortium; Diabetes Prevention Program Research Group Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 2011;60:1340–1348
    1. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979;6:65–70
    1. Jablonski KA, McAteer JB, de Bakker PI, et al. ; Diabetes Prevention Program Research Group Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Diabetes 2010;59:2672–2681
    1. Nicklas BJ, van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Genetic variation in the peroxisome proliferator-activated receptor-γ2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 2001;50:2172–2176
    1. Goyenechea E, Dolores Parra M, Alfredo Martínez J. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms. Br J Nutr 2006;96:965–972
    1. Vogels N, Mariman EC, Bouwman FG, Kester AD, Diepvens K, Westerterp-Plantenga MS. Relation of weight maintenance and dietary restraint to peroxisome proliferator-activated receptor gamma2, glucocorticoid receptor, and ciliary neurotrophic factor polymorphisms. Am J Clin Nutr 2005;82:740–746

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다